Anti-inflammatory drugs 'can cut cancer risk'

Experts in the US have suggested that certain anti-inflammatory tablets could potentially reduce the risk of developing breast cancer, after testing on mice indicated some efficacy.

Research conducted by a team at the University of Colorado and recently printed in the science journal Nature found non-steroidal anti-inflammatory drugs (NSAIDs) may prevent postpartum tumours from forming.

Once new mothers have stopped breastfeeding their young, milk-producing cells die off and are replaced with fat cells - thereby potentially leaving women more likely to contract the disease.

"A mother's body is undergoing radical changes during this time," said investigator Dr Pepper Schedin. "We can't yet speak to the safety of these drugs for women diagnosed with or at risk for postpartum breast cancer."

The study came after Tenovus associate director of research Dr Ian Lewis insisted that despite a steady improvement in survival rates, there is still a need to offer greater support to breast cancer sufferers.

Comment on this page »


Latest news

AXA PPP healthcare win at UK Customer Experience awards 2015

David Mobbs retires as CEO of Nuffield Health

King's victorious at World Transplant Games

Anti-inflammatory drugs 'can cut cancer risk'
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information